Matthew B. Klein, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 2,514 shares at $76.45 ($192K) on 2026-01-08, disclosed to the SEC on 2026-01-12.
Seasonal sale ($192k) by CHIEF EXECUTIVE OFFICER — this insider has traded PTCT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| PTCT | SELL | 2026-05-15 | $917K | — | Filing → |
| PTCT | SELL | 2026-04-23 | $202K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |